Antiemetic drug not tied to adverse pregnancy outcomes

02/27/2013 | Family Practice News

The prenatal use of ondansetron, an antiemetic for treating nausea and vomiting during pregnancy, was not linked to increased odds of still birth, preterm delivery, birth defects, or low birth weight or small-for-gestational-age babies, Danish researchers found. The study was published in the New England Journal of Medicine.

View Full Article in:

Family Practice News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Director, Global Regulatory Affairs
Rodan and Fields, LLC
San Francisco, CA
Senior Compliance Analyst
ACell, Inc.
Columbia, MD
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA